TITLE

Remicade

PUB. DATE
April 2008
SOURCE
Pharmaceutical Representative;Apr2008, Vol. 38 Issue 4, p13
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article discusses the integrated analysis of three pivotal trials presented at the 66th annual meeting of the American Academy of Dermatology in Pennsylvania. It states that patients with severe psoriasis experienced significant improvements with Remicade therapy. The three pivotal randomized placebo-controlled trials have indicated that psoriasis patients treated with Horsham, Centocor's Remicade show consistent improvement in skin clearance across different regions of their body.
ACCESSION #
31540697

 

Related Articles

  • A 52-week randomized safety study of a calcipotriol/betamethasone dipropionate two-compound product (Dovobet/Daivobet/Taclonex) in the treatment of psoriasis vulgaris.  // Current Medical Literature: Dermatology;2006, Vol. 11 Issue 4, p109 

    The article presents the findings of a study of a calcipotriol/betamethasone dipropionate two-compound product for the treatment of psoriasis vulgaris. Three treatment groups of patients were randomized, including the administration for 52 weeks of two-compound ointment, and alternating 4-week...

  • Living with Psoriasis. Paranzino, Michael // FDA Consumer;Sep2004, Vol. 38 Issue 5, p40 

    Reflects on life as a psoriasis patient. Characterization of the disease; Physical and emotional effects of psoriasis; Increase in the efforts of the U.S. government to develop psoriasis treatment.

  • Biologics' efficacy data growing. Jesitus, John // Dermatology Times;Sep2005 Supplement 4, Vol. 25, pS19 

    Reports on the advantages of longer treatment regimens and combinations with other modalities by use of biologic drugs for psoriasis treatment. Problems of alefacept; Observations on patients treated with alefacept; Advantages of combined therapies for psoriasis.

  • Offer systemic therapy as first-line defense. Rutledge, Barbara J. // Dermatology Times;Sep2005 Supplement 4, Vol. 25, pS16 

    Evaluates the efficacy of alefacept therapy as first-line defense for psoriasis. Impact of psoriasis on the quality of life of the patient; Number of people affected with the disease of the year; Treatment paradigms for psoriasis.

  • Weekday calcipotriene extends psoriasis remission.  // Modern Medicine;Dec98, Vol. 66 Issue 12, p42 

    Presents an abstract of the study `Calcipotriene ointment and halobetasol ointment in the long-term treatment of psoriasis: Effects on the duration of improvement,' by M. Lebwohl, A. Yoles, K. Lombardi, et al., which appeared in the `Journal of American Academic Dermatol,' dated September 1998.

  • Systemics remain relevant psoriasis Rx. Nataloni, Rochelle // Dermatology Times;Sep2005 Supplement 4, Vol. 25, pS18 

    Reports that systemic drugs, from cyclosporine to methotrexate has retained a relevant role in the treatment of psoriasis despite of all encompassing focus on biologics. Comments of Bruce E. Strober, assistant professor of dermatology in New York University School of Medicine, New York, on the...

  • For oral disease tx, manage dry mouth. Guttman, Cheryl // Dermatology Times;Jun2005, Vol. 26 Issue 6, p30 

    The article presents views of physician Susan L. Zunt on oral diseases at the 63th annual meeting of the American Academy of Dermatology in New Orleans. Zunt said that xerostomia can complicate the diagnosis and management of various oral diseases and is an important condition to recognize and...

  • No cure for psoriasis, but treatments can help. Pinette, Dr. Gilles // Saskatchewan Sage;Apr2004, Vol. 8 Issue 7, p13 

    Psoriasis is a common condition that causes red or purple scaly patches on your skin. Psoriasis is pronounced "sore-eye-a-sis." These patches may be thick with a rough surface, and may be on the knees, elbows and scalp or they may be widespread across the entire body. The exact cause of...

  • tazarotene.  // Royal Society of Medicine: Medicines;2002, p523 

    The article presents information on tazarotene which is chemically a derivative of retinol or vitamin A. This drug can be used to treat mild to moderate plaque psoriasis. Administration is by topical application. It should not be used in pregnancy or breast-feeding. Patients should wash hands...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics